Etaracizumab
Product Specifications
CAS Number
892553-42-3
Target
Apoptosis, Akt, Integrin
Related Pathways
PI3K/Akt/mTOR signaling, Apoptosis, Cytoskeletal Signaling
Purity
0.9932
Bioactivity
Etaracizumab (LM 609) is a humanized monoclonal antibody targeting integrin αvβ3, inhibiting angiogenesis and melanoma growth, used in the study of melanoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
